Halogens engineering-based design of agonists for boosting expression of frataxin protein in Friedreich's ataxia

CONCLUSIONS: The selected agonist is one of the most potent compounds in increasing Frataxin protein expression. Furthermore, optimization with halogens can be a productive approach to improve the candidate's drug efficacy. The development of effective medications for the treatment of Friedreich ataxia would be aided by the results of these computational investigations.PMID:37606107 | DOI:10.26355/eurrev_202308_33269
Source: Pharmacological Reviews - Category: Drugs & Pharmacology Authors: Source Type: research